FTSE on a drugs high

clock

The FTSE 100 Index closed 43 points, or 0.7%, higher at 5,856 points today led by talk Novartis is lining up a bid for AstraZeneca.

AstraZeneca gained 4.35% to 2,832p. Royal & Sun Alliance was also a top riser, gaining 1.59% to 127.50p, after it reported a strong set of final figures after a "very good" year. The insurer registered a better than expected operating result of £698m. Sector peer Aviva gained 1.33% to 799.50p after UBS raised its share price target to 810p from 740p. BAE Systems was 1.32% higher at 421.75p following a report in The Guardian, which said EADS is lining up a bid for the UK group’s 20% stake in Airbus. Meanwhile, Tesco fell 0.90% to 329p following last night’s data from research fir...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Investment

Direct engagement and the search for hidden gems

Direct engagement and the search for hidden gems

'What really matters is that investors do not find themselves behind the eight ball'

Gabriel Sacks
clock 27 October 2025 • 4 min read
Pensions tax breaks: Budget 'kite-flying' creating cash management challenge

Pensions tax breaks: Budget 'kite-flying' creating cash management challenge

Savers and advisers dealing with cash management quandary

Kate Toumazi
clock 14 October 2025 • 3 min read
Partner Insight: Finding the right partner for a managed portfolio service

Partner Insight: Finding the right partner for a managed portfolio service

Francis Clark Financial Planning set up a white-label managed portfolio service for their clients, but as the effects of COVID-19 played out and markets stagnated, they realised they needed a change. Managing Director Chris Reah explains how they found the right solution.

Chris Reah, Francis Clark Financial Planning
clock 13 October 2025 • 5 min read